E380D: a novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Mutat 1997;9(2):181-2
Date
01/01/1997Pubmed ID
9067760DOI
10.1002/(SICI)1098-1004(1997)9:2<181::AID-HUMU12>3.0.CO;2-ZScopus ID
2-s2.0-0030893822 (requires institutional sign-in at Scopus site) 12 CitationsAuthor List
Kirby-Keyser L, Porter CC, Donohoue PAAuthors
Patricia Donohoue MD Emeritus Professor in the Pediatrics department at Medical College of WisconsinCraig Porter MD Emeritus Professor in the Pediatrics department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Adrenal Hyperplasia, CongenitalBlotting, Southern
Exons
HLA Antigens
Homozygote
Humans
Pedigree
Point Mutation
Polymerase Chain Reaction
Restriction Mapping
Sequence Analysis, DNA
Steroid 21-Hydroxylase









